Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Minority Interest (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Minority Interest for 7 consecutive years, with $10.6 million as the latest value for Q4 2025.

  • Quarterly Minority Interest rose 4.42% to $10.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.6 million through Dec 2025, up 4.42% year-over-year, with the annual reading at $10.6 million for FY2025, 4.42% up from the prior year.
  • Minority Interest hit $10.6 million in Q4 2025 for BridgeBio Pharma, up from $10.3 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $12.4 million in Q3 2023 to a low of $336000.0 in Q1 2022.
  • Historically, Minority Interest has averaged $8.8 million across 5 years, with a median of $10.5 million in 2022.
  • Biggest five-year swings in Minority Interest: plummeted 73.56% in 2022 and later soared 3547.62% in 2023.
  • Year by year, Minority Interest stood at $3.4 million in 2021, then skyrocketed by 230.66% to $11.3 million in 2022, then decreased by 0.34% to $11.2 million in 2023, then decreased by 9.73% to $10.2 million in 2024, then grew by 4.42% to $10.6 million in 2025.
  • Business Quant data shows Minority Interest for BBIO at $10.6 million in Q4 2025, $10.3 million in Q3 2025, and $9.9 million in Q2 2025.